Innovative CAR T therapy could deliver in broader therapeutic settings, research suggests
By Catherine Eckford (European Pharmaceutical Review)
Landmark UK-India trade deal insufficient for life sciences, says industry body
By Catherine Eckford (European Pharmaceutical Review)
Improving EU’s regulatory framework for enhanced pharma competitiveness
By Catherine Eckford (European Pharmaceutical Review)
New J&J data signals progress in ulcerative colitis treatment landscape
By Catherine Eckford (European Pharmaceutical Review)
QbD for biopharmaceutical product lifecycle management
By Busol Park (Samsung Biologics), Youngsun Kim (Samsung Biologics)